Skip to main content

Advertisement

Log in

New persistent opioid use after bariatric surgery: a systematic review and pooled proportion meta-analysis

  • 2022 SAGES Oral
  • Published:
Surgical Endoscopy Aims and scope Submit manuscript

Abstract

Introduction

Increasing evidence suggests surgical patients are at risk for developing new, persistent opioid use (NPOU) following surgery. This risk may be heightened for patients undergoing bariatric surgery. Few studies have evaluated this important long-term outcome and little is known about the rate of NPOU, or factors associated with NPOU for bariatric surgery patients.

Methods and procedure

We conducted a systematic review of MEDLINE, Embase, Scopus, Web of Science, and Cochrane databases in August 2021. Studies were reviewed and data extracted independently by two reviewers following MOOSE guidelines. Studies evaluating bariatric surgery patients reporting NPOU, defined as new opioid use > 90 days after surgery, were included. Abstracts, non-English, animal, n < 5, and pediatric studies were excluded. Primary outcome was NPOU prevalence, and secondary outcomes were patient and surgical factors associated with NPOU. Factors associated with NPOU are reported from findings of individual studies; meta-analysis could not be completed due to heterogeneity of reporting.

Results

We retrieved a total of 2113 studies with 8 meeting inclusion criteria. In studies reporting NPOU rates (n = 4 studies), pooled prevalence was 6.0% (95% CI 4.0–7.0%). Patient characteristics reported by studies to be associated with NPOU included prior substance use (tobacco, alcohol, other prescription analgesics), preoperative mental health disorder (anxiety, mood disorders, eating disorders), and public health insurance. Surgical factors associated with NPOU included severe post-operative complications and in-hospital opioid use (peri- or post operatively).

Conclusions

NPOU is an uncommon but important complication following bariatric surgery, with patient factors including prior substance abuse, mental health disorders, and use of public health insurance placing patients at increased risk, and surgical factors being complications and peri-operative opioid use. Studies evaluating techniques to reduce NPOU in these high-risk populations are needed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Opioid overdose crisis. National Institute on Drug Abuse (NIDA). https://www.drugabuse.gov/drug-topics/opioids/opioid-overdose-crisis. Accessed 5 Jan 2022

  2. Smith ME, Lee JS, Bonham A et al (2019) Effect of new persistent opioid use on physiologic and psychologic outcomes following bariatric surgery. Surg Endosc 33(8):2649–2656. https://doi.org/10.1007/s00464-018-6542-0

    Article  Google Scholar 

  3. Heinberg LJ, Pudalov L, Alameddin H, Steffen K (2019) Opioids and bariatric surgery: a review and suggested recommendations for assessment and risk reduction. Surg Obes Relat Dis 15(2):314–321. https://doi.org/10.1016/j.soard.2018.11.019

    Article  Google Scholar 

  4. Brummett CM, Waljee JF, Goesling J et al (2017) New persistent opioid use after minor and major surgical procedures in us adults. JAMA Surg. https://doi.org/10.1001/jamasurg.2017.0504

    Article  Google Scholar 

  5. Lawal OD, Gold J, Murthy A et al (2020) Rate and risk factors associated with prolonged opioid use after surgery: a systematic review and meta-analysis. JAMA Netw Open. https://doi.org/10.1001/jamanetworkopen.2020.7367

    Article  Google Scholar 

  6. King WC, Chen JY, Belle SH et al (2017) Use of prescribed opioids before and after bariatric surgery: prospective evidence from a U.S. multicenter cohort study. Surg Obes Relat Dis 13(8):1337–1346. https://doi.org/10.1016/j.soard.2017.04.003

    Article  Google Scholar 

  7. Raebel MA, Newcomer SR, Bayliss EA et al (2014) Chronic opioid use emerging after bariatric surgery. Pharmacoepidemiol Drug Saf 23(12):1247–1257. https://doi.org/10.1002/pds.3625

    Article  Google Scholar 

  8. Koball AM, Ames G, Goetze RE (2021) Addiction transfer and other behavioral changes following bariatric surgery. Surg Clin N Am 101(2):323–333. https://doi.org/10.1016/J.SUC.2020.12.005

    Article  Google Scholar 

  9. Stone AA, Broderick JE (2012) Obesity and pain are associated in the United States. Obesity 20(7):1491–1495. https://doi.org/10.1038/oby.2011.397

    Article  Google Scholar 

  10. Wallén S, Szabo E, Palmetun-Ekbäck M, Näslund I (2018) Use of opioid analgesics before and after gastric bypass surgery in Sweden: a population-based study. Obes Surg 28(11):3518–3523. https://doi.org/10.1007/s11695-018-3377-7

    Article  Google Scholar 

  11. Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ (Online) 339(7716):332–336. https://doi.org/10.1136/bmj.b2535

    Article  Google Scholar 

  12. Brooke BS, Schwartz TA, Pawlik TM (2021) MOOSE reporting guidelines for meta-analyses of observational studies. JAMA Surg 156(8):787–788. https://doi.org/10.1001/jamasurg.2021.0522

    Article  Google Scholar 

  13. Haddaway NR, Collins AM, Coughlin D, Kirk S (2015) The role of Google Scholar in evidence reviews and its applicability to grey literature searching. PLoS ONE. https://doi.org/10.1371/journal.pone.0138237

    Article  Google Scholar 

  14. Slim K, Nini E, Forestier D et al (2003) Methodological index for non-randomized studies (MINORS): development and validation of a new instrument. ANZ J Surg 73(9):712–716

    Article  Google Scholar 

  15. Khan W, Khan M, Alradwan H, Williams R, Simunovic N, Ayeni OR (2015) Utility of intra-articular hip injections for femoroacetabular impingement: a systematic review. Orthop J Sports Med. https://doi.org/10.1177/2325967115601030

    Article  Google Scholar 

  16. Wan X, Wang W, Liu J, Tong T (2014) Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol 14:135. http://www.biomedcentral.com/1471-2288/14/135. Accessed 15 Jan 2022

  17. Higgins JPT, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ (Clin Res Ed) 327(7414):557–560. https://doi.org/10.1136/BMJ.327.7414.557

    Article  Google Scholar 

  18. Veritas Health Information. Covidence systematic review software. www.covidence.org. Accessed 13 Nov 2021

  19. Sheldon RR, Holtestaul TA, Morte DR, Jones IF, Forte DM, Bingham JR (2020) Influence of preoperative psychotropic medications on opioid requirements and outcomes following bariatric surgery: psychotropic medications and bariatric surgery. Am J Surg 219(5):841–845. https://doi.org/10.1016/j.amjsurg.2020.03.019

    Article  Google Scholar 

  20. Vidarsson B, Löfling Skogar M, Sundbom M (2021) Impact of a severe complication two years after laparoscopic Roux-en-Y gastric bypass: a cohort study from the Scandinavian Obesity Surgery Registry. Surg Obes Relat Dis. https://doi.org/10.1016/j.soard.2021.06.023 (Published online 2021)

    Article  Google Scholar 

  21. Lent MR, Avakoff E, Hope N et al (2018) Clinical characteristics of Roux-en-Y gastric bypass patients with death from accidental overdose or intentional self-harm: a descriptive study. Obes Surg 28(11):3531–3537. https://doi.org/10.1007/s11695-018-3379-5

    Article  Google Scholar 

  22. Saules KK, Wiedemann A, Ivezaj V, Hopper JA, Foster-Hartsfield J, Schwarz D (2010) Bariatric surgery history among substance abuse treatment patients: prevalence and associated features. Surg Obes Relat Dis 6(6):615–621. https://doi.org/10.1016/j.soard.2009.12.008

    Article  Google Scholar 

  23. Clarke H, Soneji N, Ko DT, Yun L, Wijeysundera DN (2014) Rates and risk factors for prolonged opioid use after major surgery: population based cohort study. BMJ. https://doi.org/10.1136/BMJ.G1251

    Article  Google Scholar 

  24. Rates and risk factors for prolonged opioid use after major surgery: population based cohort study. https://doi.org/10.1136/bmj.g1251

  25. Estimate of bariatric surgery numbers, 2011–2019. American Society for Metabolic and Bariatric Surgery. https://asmbs.org/resources/estimate-of-bariatric-surgery-numbers. Accessed 27 Dec 2021

  26. Brummett CM, Evans-Shields J, England C et al. Increased health care costs associated with new persistent opioid use after major surgery in opioid-naive patients. https://doi.org/10.18553/jmcp.2021.20507

  27. Lee JS, Vu J V, Edelman AL et al. Healthcare spending and new persistent opioid use after surgery. https://doi.org/10.1097/SLA.0000000000003399

  28. Sullivan MD, Edlund MJ, Zhang L. Association between mental health disorders, problem drug use, and regular prescription opioid use. https://jamanetwork.com/. Accessed 15 March 2021

  29. Burns S, Urman R, Pian R, Jim O, Coppes M. Reducing new persistent opioid use after surgery: a review of interventions. Published online 1916. https://doi.org/10.1007/s11916-021-00943-6

  30. Lloret-Linares C, Hirt D, Bardin C et al (2014) Effect of a Roux-en-Y gastric bypass on the pharmacokinetics of oral morphine using a population approach. Clin Pharmacokinet 53(10):919–930. https://doi.org/10.1007/s40262-014-0163-0

    Article  CAS  Google Scholar 

  31. Angeles PC, Robertsen I, Seeberg LT et al (2019) The influence of bariatric surgery on oral drug bioavailability in patients with obesity: a systematic review. Obes Rev 20(9):1299–1311. https://doi.org/10.1111/obr.12869

    Article  Google Scholar 

  32. Brutman JN, Sirohi S, Davis JF (2019) Recent advances in the neurobiology of altered motivation following bariatric surgery. Curr Psychiatry Rep. https://doi.org/10.1007/s11920-019-1084-2

    Article  Google Scholar 

  33. Jones T, Moore T, Levy JL et al (2012) A comparison of various risk screening methods in predicting discharge from opioid treatment. www.clinicalpain.com. Accessed 15 March 2021

  34. Chaw SH, Yoke, Lo L et al. Transversus abdominis plane block versus intraperitoneal local anesthetics in bariatric surgery: a systematic review and network meta-analysis. https://doi.org/10.1007/s11695-021-05564-x

Download references

Funding

There is no funding or grant support for this study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kevin Verhoeff.

Ethics declarations

Disclosures

Khadija Nasser, Kevin Verhoeff, Valentin Mocanu, Janice Y. Kung, Kieran Purich, Noah J. Switzer, Daniel W. Birch, and Shahzeer Karmali have no conflicts of interest or financial ties to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Appendix

Appendix

Search strategies

Database

Search strategy

MEDLINE

Ovid MEDLINE(R) ALL 1946 to August 19, 2021

1. bariatric*.mp. or exp Bariatric Surgery/

2. exp Biliopancreatic Diversion/ or (biliopancreatic diversion* or biliopancreatic bypass).mp

3. duodenal switch*.mp

4. (gastric bypass* or gastric surger*).mp

5. exp Gastroenterostomy/ or gastroenterostom*.mp

6. gastrogastrostom*.mp

7. gastrojejunostom*.mp

8. gastroileal bypass.mp

9. gastroplast*.mp

10. intestin* bypass.mp. or exp Jejunoileal Bypass/

11. ((jejunoileal or jejuno-ileal or jejunoilial or jejuno-ilial or jejunocolic) adj bypass).mp

12. mason* procedure*.mp

13. ((obesity or obese or weight) adj5 surg*).mp

14. exp Obesity/su [Surgery]

15. restrictive surger*.mp

16. roux-en-y.mp. or exp Anastomosis, Roux-en-Y/

17. scopinaro.mp

18. sleeve gastrectom*.mp

19. ((stomach or gastric) adj5 stapl*).mp

20. (SADI or SADI-S or single anastomosis duodeno*).mp

21. or/1-20

22. (Abstral or Actiq or Alfentanil or Anexsia or Astramorph or Avinza or buprenorphine or Butrans or carfentan* or Codeine or Co-Gesic or Demerol or dextropropoxyphene or Diamorphine or Dilaudid or Dolophine or Duragesic or Embeda or Endocet or Exalgo or Fentanyl or Fentora or heroin or Hycet or Hycodan or Hydrocodone or Hydromet or hydromorphone or Hysingla or Ibudone or Kadian or levorphanol or levopropoxyphene or Liquicet or Lorcet or Lortab or Maxidone or meperidine or Morphabond or morphine or MS Contin or Nalbuphine or narcotic* or Norco or Nubain or Nucynta ER or Opana ER or opiate* or opioid* or opium or Onsolis or Oramorph or Ora-Morph or Oxaydo or Oxecta or Oxycet or oxycodone or OxyContin or Oxymorphone hydrochloride or Palladone or Pentazocine or Percocet or Percodan or Pethidine or Reprexain or Rezira or Roxanol* or Roxicet or Roxicodone or Roxycodone or Sublimaze or Sufentanil or tapentadol or Targiniq ER or tramacet or tramadol or TussiCaps or Tussionex or Tuzistra XR or Vicodin or Vicoprofen or Vituz or Xartemis XR or Xodol or Xtampza ER or Zohydro ER or Zolvit or Zutripro or Zydone).mp

23. exp Opioid-Related Disorders/

24. exp Analgesics, Opioid/

25. or/22-24

26. (post-operative* or postoperative* or post-surg* or postsurg*).mp

27. ((post or after or follow*) adj3 (operat* or surg* or procedur* or gastrectom* or roux-en-y or bypass or gastric or sleeve)).mp

28. Pain, Postoperative/

29. Postoperative Complications/

30. or/26-29

31. 21 and 25 and 30

32. animals/

33. humans/

34. 32 not (32 and 33)

35. (veterinary or rabbit or rabbits or animal or animals or mouse or mice or rodent or rodents or rat or rats or murine or hamster* or pig or pigs or piglets or swine or porcine or horse* or equine or cow or cows or cattle or bovine or goat or goats or sheep or lambs or ovine or monkey or monkeys or trout or marmoset$1 or canine or dog or dogs or feline or cat or cats or zebrafish).ti

36. 34 or 35

37. 31 not 36

38. limit 37 to english language

Embase

Ovid Embase 1974 to 2021 August 19

1. bariatric*.mp. or exp bariatric surgery/

2. exp biliopancreatic bypass/ or (biliopancreatic diversion* or biliopancreatic bypass).mp

3. duodenal switch*.mp

4. (gastric bypass* or gastric surger*).mp

5. exp gastroenterostomy/ or gastroenterostom*.mp

6. gastrogastrostom*.mp

7. gastrojejunostom*.mp

8. gastroileal bypass.mp

9. gastroplast*.mp

10. intestin* bypass.mp. or exp jejunoileal bypass/

11. ((jejunoileal or jejuno-ileal or jejunoilial or jejuno-ilial or jejunocolic) adj bypass).mp

12. mason* procedure*.mp

13. ((obesity or obese or weight) adj5 surg*).mp

14. exp obesity/su [Surgery]

15. restrictive surger*.mp

16. roux-en-y.mp. or exp Roux Y anastomosis/

17. scopinaro.mp

18. sleeve gastrectom*.mp

19. ((stomach or gastric) adj5 stapl*).mp

20. (SADI or SADI-S or single anastomosis duodeno*).mp

21. or/1-20

22. (Abstral or Actiq or Alfentanil or Anexsia or Astramorph or Avinza or buprenorphine or Butrans or carfentan* or Codeine or Co-Gesic or Demerol or dextropropoxyphene or Diamorphine or Dilaudid or Dolophine or Duragesic or Embeda or Endocet or Exalgo or Fentanyl or Fentora or heroin or Hycet or Hycodan or Hydrocodone or Hydromet or hydromorphone or Hysingla or Ibudone or Kadian or levorphanol or levopropoxyphene or Liquicet or Lorcet or Lortab or Maxidone or meperidine or Morphabond or morphine or MS Contin or Nalbuphine or narcotic* or Norco or Nubain or Nucynta ER or Opana ER or opiate* or opioid* or opium or Onsolis or Oramorph or Ora-Morph or Oxaydo or Oxecta or Oxycet or oxycodone or OxyContin or Oxymorphone hydrochloride or Palladone or Pentazocine or Percocet or Percodan or Pethidine or Reprexain or Rezira or Roxanol* or Roxicet or Roxicodone or Roxycodone or Sublimaze or Sufentanil or tapentadol or Targiniq ER or tramacet or tramadol or TussiCaps or Tussionex or Tuzistra XR or Vicodin or Vicoprofen or Vituz or Xartemis XR or Xodol or Xtampza ER or Zohydro ER or Zolvit or Zutripro or Zydone).ti,ab,kw

23. exp *opiate addiction/

24. exp *narcotic analgesic agent/

25. or/22-24

26. (post-operative* or postoperative* or post-surg* or postsurg*).mp

27. ((post or after or follow*) adj3 (operat* or surg* or procedur* or gastrectom* or roux-en-y or bypass or gastric or sleeve)).mp

28. postoperative pain/

29. postoperative complication/

30. or/26-29

31. 21 and 25 and 30

32. animal/

33. human/

34. 32 not (32 and 33)

35. (veterinary or rabbit or rabbits or animal or animals or mouse or mice or rodent or rodents or rat or rats or murine or hamster* or pig or pigs or piglets or swine or porcine or horse* or equine or cow or cows or cattle or bovine or goat or goats or sheep or lambs or ovine or monkey or monkeys or trout or marmoset$1 or canine or dog or dogs or feline or cat or cats or zebrafish).ti

36. 34 or 35

37. 31 not 36

38. limit 37 to english language

Scopus

(TITLE-ABS-KEY ((obesity OR obese OR weight) W/4 surg*) OR TITLE-ABS-KEY (bariatric* OR "biliopancreatic diversion*" OR "biliopancreatic bypass" OR "duodenal switch*" OR "gastric band*" OR "gastric bypass*" OR "gastric surger*" OR gastroenterostom* OR gastrogastrostom* OR gastrojejunostom* OR "gastroileal bypass" OR gastroplast* OR "intestin* bypass" OR "jejunoileal bypass" OR "jejuno-ileal bypass" OR "jejunoilial bypass" OR "jejuno-ilial bypass" OR "jejunocolic bypass" OR "lap band*" OR "mason* procedure" OR "roux-en-y" OR "silicon band*" OR scopinaro OR "sleeve gastrectom*" OR sadi OR sadi-s OR "single anastomosis duodeno*") OR TITLE-ABS-KEY ((stomach OR gastric) W/4 stapl*)) AND TITLE-ABS-KEY (abstral OR actiq OR alfentanil OR anexsia OR astramorph OR avinza OR buprenorphine OR butrans OR carfentan* OR codeine OR co-gesic OR demerol OR dextropropoxyphene OR diamorphine OR dilaudid OR dolophine OR duragesic OR embeda OR endocet OR exalgo OR fentanyl OR fentora OR heroin OR hycet OR hycodan OR hydrocodone OR hydromet OR hydromorphone OR hysingla OR ibudone OR kadian OR levorphanol OR levopropoxyphene OR liquicet OR lorcet OR lortab OR maxidone OR meperidine OR morphabond OR morphine OR "MS Contin" OR nalbuphine OR narcotic* OR norco OR nubain OR "Nucynta ER" OR "Opana ER" OR opiate* OR opioid* OR opium OR onsolis OR oramorph OR ora-morph OR oxaydo OR oxecta OR oxycet OR oxycodone OR oxycontin OR "oxymorphone hydrochloride" OR palladone OR pentazocine OR percocet OR percodan OR pethidine OR reprexain OR rezira OR roxanol* OR roxicet OR roxicodone OR roxycodone OR sublimaze OR sufentanil OR tapentadol OR "Targiniq ER" OR tramacet OR tramadol OR tussicaps OR tussionex OR "Tuzistra XR" OR vicodin OR vicoprofen OR vituz OR "Xartemis XR" OR xodol OR "Xtampza ER" OR "Zohydro ER" OR zolvit OR zutripro OR zydone) AND TITLE-ABS-KEY (post-operative* OR postoperative* OR post-surg* OR postsurg* OR ( post W/3 ( operat* OR surg* OR procedur* OR gastrectom* OR roux-en-y OR bypass OR gastric OR sleeve)) OR ( after W/3 ( operat* OR surg* OR procedur* OR gastrectom* OR roux-en-y OR bypass OR gastric OR sleeve)) OR (follow* W/3 ( operat* OR surg* OR procedur* OR gastrectom* OR roux-en-y OR bypass OR gastric OR sleeve))) AND NOT TITLE (veterinary OR rabbit OR rabbits OR animal OR animals OR mouse OR mice OR rodent OR rodents OR rat OR rats OR murine OR hamster* OR pig OR pigs OR piglets OR swine OR porcine OR horse* OR equine OR cow OR cows OR cattle OR bovine OR goat OR goats OR sheep OR lambs OR ovine OR monkey OR monkeys OR trout OR marmoset$1 OR canine OR dog OR dogs OR feline OR cat OR cats OR zebrafish) AND ( LIMIT-TO (LANGUAGE, "English"))

Web of Science Core Collection

(TS = ((obesity OR obese OR weight) NEAR/4 surg*) OR TS = (bariatric* OR "biliopancreatic diversion*" OR "biliopancreatic bypass" OR "duodenal switch*" OR "gastric band*" OR "gastric bypass*" OR "gastric surger*" OR gastroenterostom* OR gastrogastrostom* OR gastrojejunostom* OR "gastroileal bypass" OR gastroplast* OR "intestin* bypass" OR "jejunoileal bypass" OR "jejuno-ileal bypass" OR "jejunoilial bypass" OR "jejuno-ilial bypass" OR "jejunocolic bypass" OR "lap band*" OR "mason* procedure" OR "roux-en-y" OR "silicon band*" OR scopinaro OR "sleeve gastrectom*" OR sadi OR sadi-s OR "single anastomosis duodeno*") OR TS = ((stomach OR gastric) NEAR/4 stapl*)) AND TS = (abstral OR actiq OR alfentanil OR anexsia OR astramorph OR avinza OR buprenorphine OR butrans OR carfentan* OR codeine OR co-gesic OR demerol OR dextropropoxyphene OR diamorphine OR dilaudid OR dolophine OR duragesic OR embeda OR endocet OR exalgo OR fentanyl OR fentora OR heroin OR hycet OR hycodan OR hydrocodone OR hydromet OR hydromorphone OR hysingla OR ibudone OR kadian OR levorphanol OR levopropoxyphene OR liquicet OR lorcet OR lortab OR maxidone OR meperidine OR morphabond OR morphine OR "MS Contin" OR nalbuphine OR narcotic* OR norco OR nubain OR "Nucynta ER" OR "Opana ER" OR opiate* OR opioid* OR opium OR onsolis OR oramorph OR ora-morph OR oxaydo OR oxecta OR oxycet OR oxycodone OR oxycontin OR "oxymorphone hydrochloride" OR palladone OR pentazocine OR percocet OR Percodan OR Pethidine OR reprexain OR rezira OR roxanol* OR roxicet OR roxicodone OR roxycodone OR sublimaze OR sufentanil OR tapentadol OR "Targiniq ER" OR tramacet OR tramadol OR tussicaps OR tussionex OR "Tuzistra XR" OR vicodin OR vicoprofen OR vituz OR "Xartemis XR" OR xodol OR "Xtampza ER" OR "Zohydro ER" OR zolvit OR zutripro OR zydone) AND TS = (post-operative* OR postoperative* OR post-surg* OR postsurg* OR ( post NEAR/3 ( operat* OR surg* OR procedur* OR gastrectom* OR roux-en-y OR bypass OR gastric OR sleeve)) OR (after NEAR/3 (operat* OR surg* OR procedur* OR gastrectom* OR roux-en-y OR bypass OR gastric OR sleeve)) OR ( follow* NEAR/3 (operat* OR surg* OR procedur* OR gastrectom* OR roux-en-y OR bypass OR gastric OR sleeve))) NOT TI = (veterinary OR rabbit OR rabbits OR animal OR animals OR mouse OR mice OR rodent OR rodents OR rat OR rats OR murine OR hamster* OR pig OR pigs OR piglets OR swine OR porcine OR horse* OR equine OR cow OR cows OR cattle OR bovine OR goat OR goats OR sheep OR lambs OR ovine OR monkey OR monkeys OR trout OR marmoset$1 OR canine OR dog OR dogs OR feline OR cat OR cats OR zebrafish)

Languages: English

Cochrane Library via Wiley

#1 bariatric*

#2 MeSH descriptor: [Bariatric Surgery] 2 tree(s) exploded

#3 MeSH descriptor: [Biliopancreatic Diversion] explode all trees

#4 biliopancreatic NEXT diversion*

#5 duodenal NEXT switch*

#6 (gastric NEXT band*) or (gastric NEXT bypass*) or (gastric NEXT surger*)

#7 MeSH descriptor: [Gastroenterostomy] explode all trees

#8 gastroenterostom*

#9 gastrogastrostom*

#10 gastrojejunostom*

#11 gastroileal bypass

#12 gastroplast*

#13 MeSH descriptor: [Jejunoileal Bypass] 4 tree(s) exploded

#14 intestin* NEXT bypass

#15 ((jejunoileal or jejuno-ileal or jejunoilial or jejuno-ilial or jejunocolic) NEAR/1 bypass)

#16 lap NEXT band*

#17 mason* NEXT procedure*

#18 ((obesity or obese or weight) NEAR/4 surg*)

#19 MeSH descriptor: [Obesity] explode all trees and with qualifier(s): [surgery – SU]

#20 restrictive NEXT surger*

#21 MeSH descriptor: [Anastomosis, Roux-en-Y] explode all trees

#22 roux-en-y

#23 scopinaro

#24 silicon NEXT band*

#25 sleeve NEXT gastrectom*

#26 ((stomach or gastric) NEAR/5 stapl*)

#27 SADI or SADI-S or single anastomosis duodeno*

#28 {OR #1-#27}

#29 Abstral or Actiq or Alfentanil or Anexsia or Astramorph or Avinza or buprenorphine or Butrans or carfentan* or Codeine or Co-Gesic or Demerol or dextropropoxyphene or Diamorphine or Dilaudid or Dolophine or Duragesic or Embeda or Endocet or Exalgo or Fentanyl or Fentora or heroin or Hycet or Hycodan or Hydrocodone or Hydromet or hydromorphone or Hysingla or Ibudone or Kadian or levorphanol or levopropoxyphene or Liquicet or Lorcet or Lortab or Maxidone or meperidine or Morphabond or morphine or MS Contin or Nalbuphine or narcotic* or Norco or Nubain or Nucynta ER or Opana ER or opiate* or opioid* or opium or Onsolis or Oramorph or Ora-Morph or Oxaydo or Oxecta or Oxycet or oxycodone or OxyContin or Oxymorphone hydrochloride or Palladone or Pentazocine or Percocet or Percodan or Pethidine or Reprexain or Rezira or Roxanol* or Roxicet or Roxicodone or Roxycodone or Sublimaze or Sufentanil or tapentadol or Targiniq ER or tramacet or tramadol or TussiCaps or Tussionex or Tuzistra XR or Vicodin or Vicoprofen or Vituz or Xartemis XR or Xodol or Xtampza ER or Zohydro ER or Zolvit or Zutripro or Zydone

#30 [mh "Opioid-Related Disorders"]

#31 [mh "Analgesics, Opioid"]

#32 {OR #29-#31}

#33 post-operative* or postoperative* or post-surg* or postsurg*

#34 ((post or after or follow*) NEAR/3 (operat* or surg* or procedur* or gastrectom* or roux-en-y or bypass or gastric or sleeve))

#35 [mh "Pain, Postoperative"]

#36 [mh "Postoperative Complications"]

#37 {OR #33-#36}

#38 #28 AND #32 AND #37

Google Scholar

(bariatric surgery OR sleeve gastrectomy OR roux-en-y OR gastric bypass) AND (opioid OR opiate OR analgesic) AND (post-surgery OR post-operative OR after surgery)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nasser, K., Verhoeff, K., Mocanu, V. et al. New persistent opioid use after bariatric surgery: a systematic review and pooled proportion meta-analysis. Surg Endosc 37, 703–714 (2023). https://doi.org/10.1007/s00464-022-09291-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00464-022-09291-x

Keywords

Navigation